Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

被引:0
作者
Hongyun Zhao
Yee Chan-Li
Samuel L Collins
Yuan Zhang
Robert W Hallowell
Wayne Mitzner
Maureen R Horton
机构
[1] Johns Hopkins University School of Medicine,Department of Medicine
[2] Johns Hopkins University Bloomberg School of Public Health,Departments of Environmental Health Sciences, Division of Physiology
[3] Tongji University,Department of Respiratory Medicine, Shanghai Pulmonary Hospital, School of Medicine
来源
BMC Pulmonary Medicine | / 14卷
关键词
Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Bleomycin; Lung Fibrosis; Intratracheal Administration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 437 条
[1]  
Katzenstein AL(1998)Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification Am J Respir Crit Care Med 157 1301-1315
[2]  
Myers JL(2006)Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 810-816
[3]  
Raghu G(1996)Cytokines in human lung fibrosis Arch Toxicol Suppl 18 127-139
[4]  
Weycker D(2006)Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis Proc Am Thorac Soc 3 357-363
[5]  
Edelsberg J(2005)Eicosanoids: mediators and therapeutic targets in fibrotic lung disease Clin Sci (Lond) 108 479-491
[6]  
Bradford WZ(2009)Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis Eur Respir J 34 1444-1451
[7]  
Oster G(2010)Role of prostaglandins in fibroblast activation and fibrosis J Cell Commun Signal 4 75-77
[8]  
Martinet Y(2011)Prostaglandin E(2) protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction Am J Physiol Lung Cell Mol Physiol 301 L645-L655
[9]  
Menard O(2006)COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol 291 L144-L156
[10]  
Vaillant P(2000)Fish oil and rheumatoid arthritis: antiinflammatory and collateral health benefits J Rheumatol 27 2305-2307